Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElixirr International Regulatory News (ELIX)

Share Price Information for Elixirr International (ELIX)

Share Price is delayed by 15 minutes
Get Live Data
700.00    14.00 (2.04%)
Bid:
690.00
Ask:
708.00
Spread: 18.00 (2.609%)
Market Cap: £346.93m
ELIX Live PriceLast checked at - London Stock Exchange

Intraday Elixirr International Share Chart

Director/PDMR Shareholding

20 Dec 2024 16:20

RNS Number : 0005R
Elixirr International PLC
20 December 2024
 

 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or "Group")

Director/PDMR Shareholding

Elixirr International plc (AIM:ELIX), an established, global, award-winning, challenger consultancy, announces the exercise of options over 112,200 ordinary shares in the capital of the Company ("Ordinary Shares") by Daniel Garsin, Partner & PDMR, at an exercise price of 43.365p per share. These options were granted in May 2020.

This exercise has been satisfied from existing shares held in the Elixirr International plc Employee Benefit Trust and as a result there is no dilution in the equity of the Company. No shares are being sold by Daniel to cover the exercise price.

Following the exercise, Daniel holds a total of 326,363 Ordinary Shares representing approximately 0.68% of the Company's issued share capital.

Enquiries: 

For enquiries, please refer to our Investor Contacts page:

https://www.elixirr.com/investors/investor-contacts

Elixirr International plc +44 (0)20 7220 5410  

Stephen Newton, Chief Executive Officer

Graham Busby, Chief Financial Officer

investor-relations@elixirr.com

Cavendish Capital Markets Ltd (Nominated Adviser & Broker) +44 (0)20 7220 0500

Stephen Keys, Callum Davidson (Corporate Finance),

Sunila De Silva (ECM)

 

About Elixirr International plc

Elixirr is an award-winning global consulting firm working with clients across a diverse range of industries, markets and geographies.

Founded in 2009, the firm set out to be the 'challenger consultancy' and do things differently than the large corporate consultancies dominating the industry: working openly and collaboratively with clients from start to finish, delivering outcomes based on innovative thinking, not methodology, and treating each client's business like their own. Elixirr has been quoted on the AIM market of the London Stock Exchange since 2020. In addition to strong organic growth, Elixirr has acquired seven boutique firms - Den Creative, Coast Digital, The Retearn Group, iOLAP, Responsum, Insigniam and Hypothesis - to grow the Group's capabilities, diversify the business, expand into new geographies and access new clients.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Garsin

2. 

Reason for the Notification

a)

Position/status

Partner & PDMR

b)

Initial notification/Amendment

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Exercise of options over Ordinary Shares

c)

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

43.365p

112,200

 

d)

Aggregated information:

· Aggregated volume

· Price

 

N/A - single transaction

e)

Date of the transaction

20 December 2024

f)

Place of the transaction

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEUFMSELSEFE
Date   Source Headline
13th Jun 20221:00 pmRNSResult of AGM
19th May 20227:00 amRNSPosting of Annual Report & Accounts
29th Apr 20224:07 pmRNSResult of Secondary Placing
28th Apr 20224:06 pmRNSProposed Secondary Placing
8th Apr 20224:15 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSFinal Results
18th Mar 20227:00 amRNSAcquisition of iOLAP and FY2022 Earnings
1st Feb 20227:00 amRNSTrading Update
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
13th Oct 202111:41 amRNSResult of Secondary Placing
13th Oct 20217:00 amRNSProposed Secondary Placing
27th Sep 20217:00 amRNSInterim Results
17th Jun 20218:13 amRNSDirector/PDMR Shareholding
16th Jun 202112:21 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
24th May 20217:00 amRNSPosting of Annual Report & Notice of AGM
12th May 20213:52 pmRNSResult of Secondary Placing
12th May 20212:09 pmRNSProposed Secondary Placing
30th Apr 20214:15 pmRNSResult of General Meeting
27th Apr 20214:12 pmRNSGrant of Share Options
14th Apr 20217:00 amRNSCircular and Notice of GM
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20212:06 pmRNSSecond Price Monitoring Extn
13th Apr 20212:01 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSAcquisition of Retearn Group Limited
12th Apr 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSDirector/PCA Dealings
8th Feb 20218:00 amRNSTrading Update
21st Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20208:00 amRNSHolding(s) in Company
17th Dec 20207:00 amRNSHolding(s) in Company
16th Dec 20207:00 amRNSHolding(s) in Company
11th Dec 20207:00 amRNSResult of Secondary Placing
10th Dec 20203:57 pmRNSProposed Secondary Placing
13th Nov 20207:00 amRNSPDMR Dealing
2nd Nov 20202:05 pmRNSPDMR Dealing
29th Oct 20207:00 amRNSAcquisition of Coast Digital Limited
19th Oct 20207:00 amRNSTrading Update
15th Sep 20207:00 amRNSInterim Results
11th Aug 20207:00 amRNSPCA Shareholding
27th Jul 20207:00 amRNSPDMR Dealing
22nd Jul 20207:00 amRNSPCA Dealing
14th Jul 20205:15 pmRNSHolding(s) in Company
9th Jul 20208:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.